Paraviral exanthems

References

• Lipsker D, Saurat JH. A new concept: paraviral eruptions. Dermatology. 2005;211:309–311.
   PubMed Web of Science ®Google Scholar
• Drago F, Rebora A. Pityriasis rosea: one virus, two viruses, more viruses? Br J Dermatol. 2001;144:1086–1099.
   PubMed Web of Science ®Google Scholar
• Chuh AAT. A prospective case control study of autoimmune markers in patients with pityriasis rosea. Clin Exp Dermatol. 2003;28:449–450.
   PubMed Web of Science ®Google Scholar
• Ozyürek GD, Alan S, Cenesizoğlu E. Evaluation of clinico-epidemiological and histopathological features of pityriasis rosea. Postepy Dermatol Alergol. 2014;31:216–221.
   PubMed Web of Science ®Google Scholar
• Chuh A. The association of hyperimmunoglobulin E syndrome and Gianotti-Crosti syndrome – speculations on the roles of atopy and immunoglobulin E in a viral exanthem. Pediatr Infect Dis J. 2005;24:942.
   PubMed Web of Science ®Google Scholar
• Bilenchi R, De Paola M, Poggiali S, et al. Papular-purpuric “gloves and socks” syndrome. G Ital Dermatol Venereol. 2012;147:119–121.
   PubMed Web of Science ®Google Scholar
• Chuh A, Zawar V, Law M, et al. Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. Infect Dis Rep. 2012;4:38–48.
   Google Scholar
• Drago F, Ciccarese G, Rebora A. Unilateral laterothoracic or asymmetric periflexural exanthem: is time to change the name of the disease? Clin Exp Dermatol. 2015;40:570.
   PubMed Web of Science ®Google Scholar
• Chuh AAT, Chan HHL. Unilateral mediothoracic exanthem – a variant of unilateral laterothoracic exanthem – original description of two patients. Cutis. 2006;77:29–32.
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim BJ, Park HJ, et al. Clinicopathologic review of eruptive pseudoangiomatosis in Korean adults: report of 32 cases. Int J Dermatol. 2013;52:41–45.
   PubMed Web of Science ®Google Scholar
• Loukeris D, Serelis J, Aroni K, et al. Simultaneous occurrence of pure red cell aplasia and papular-purpuric ‘gloves and socks’ syndrome in parvovirus B-19 infection. J Eur Acad Dermatol Venereol. 2005;19:373–376.
   PubMed Web of Science ®Google Scholar
• Elena-González A, Lozano-Durán C, Cuadros-Tito P, et al. Papular-purpuric gloves and socks syndrome and thrombocytopenia related to parvovirus B19 infection. Enferm Infecc Microbiol Clin. 2014;32:61–62.
   PubMed Web of Science ®Google Scholar
• Drago F, Broccolo F, Zaccaria E, et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol. 2008;58(5Suppl 1):S78–83.
   PubMed Web of Science ®Google Scholar
• Drago F, Broccolo F, Javor S, et al. Evidence of human herpesvirus-6 and −7 reactivation in miscarrying women with pityriasis rosea. J Am Acad Dermatol. 2014;71:198–199.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Matsusaka K, Aburatani H, et al. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res. 2012;72:3445–3450.
   PubMed Web of Science ®Google Scholar
• Chuh AAT, Chan HHL. The effect on quality of life in patients with pityriasis rosea – is it associated with rash severity? Int J Dermatol. 2005;44:372–377.
   PubMed Web of Science ®Google Scholar
• Chuh A, Dofitas B, Comisel G, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007;2:CD005068.
   PubMed Web of Science ®Google Scholar
• Ayanlowo O, Akinkugbe A, Olumide Y. The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution. Nig Q J Hosp Med. 2010;20:29–31.
   PubMedGoogle Scholar
• Chuh A, Lee A, Molinari N. Case clustering in pityriasis rosea – a multi-center epidemiologic study in primary care settings in Hong Kong. Arch Dermatol. 2003;139:489–493.
   PubMedGoogle Scholar
• Chuh A, Molinari N, Sciallis G, et al. Temporal case clustering in pityriasis rosea – a regression analysis on 1,379 patients in Minnesota, Kuwait and Diyarbakýr, Turkey. Arch Dermatol. 2005;141:767–771.
   PubMedGoogle Scholar
• Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61:303–318.
   PubMed Web of Science ®Google Scholar
• Drago F, Ranieri E, Malaguti F, et al. Human herpesvirus 7 in pityriasis rosea. Lancet. 1997;349:1367–1368.
   PubMed Web of Science ®Google Scholar
• Drago F, Ranieri E, Malaguti F, et al. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology. 1997;195:374–378.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol. 2002;119:793–797.
   PubMed Web of Science ®Google Scholar
• Canpolat Kirac B, Adisen E, Bozdayi G, et al. The role of human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J Eur Acad Dermatol Venereol. 2009;23:16–21.
   PubMed Web of Science ®Google Scholar
• Drago F, Ciccarese G, Rebora A, et al. Relapsing pityriasis rosea. Dermatology. 2014;229:316–318.
   PubMed Web of Science ®Google Scholar
• Drago F, Broccolo F, Ciccarese G, et al. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. Dermatology. 2015;230:23–26.
   PubMed Web of Science ®Google Scholar
• Wong WR, Tsai CY, Shih SR, et al. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei. J Formos Med Assoc. 2001;100:478–483.
   PubMed Web of Science ®Google Scholar
• Chuh AA, Chiu SS, Peiris JS. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study. Acta Derm Venereol. 2001;81:289–290.
   PubMed Web of Science ®Google Scholar
• Karabulut AA, Koçak M, Yilmaz N, et al. Detection of human herpesvirus 7 in pityriasis rosea by nested PCR. Int J Dermatol. 2002;41:563–567.
   PubMed Web of Science ®Google Scholar
• Yildirim M, Aridogan BC, Baysal V, et al. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea. Int J Clin Pract. 2004;58:119–121.
   PubMed Web of Science ®Google Scholar
• Drago F, Ciccarese G1, Rebora A, et al. The efficacy of macrolides and acyclovir in pityriasis rosea. Indian J Dermatol Venereol Leprol. 2015;81:56.
   PubMed Web of Science ®Google Scholar
• Drago F, Broccolo F, Zaccaria E, et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol. 2008;58(5Suppl 1):S78–83.
   PubMed Web of Science ®Google Scholar
• Drago F, Broccolo F, Javor S, et al. Evidence of human herpesvirus-6 and −7 reactivation in miscarrying women with pityriasis rosea. J Am Acad Dermatol. 2014;71:198–199.
   PubMed Web of Science ®Google Scholar
• Zaruba F, Kudela A, Belsan I. Treatment of pityriasis rosea Gibert with rivanol. Cesk Dermatol. 1968;43:407–409.
   PubMedGoogle Scholar
• Lazaro-Medina A, Villena-Amurao C, Dy-Chua NS, et al. A clinicohistopathologic study of a randomized double-blind clinical trial using oral dexchlorpheniramine 4 mg, betamethasone 500 mcg and betamethasone 250 mcg with dexchlorpheniramine 2 mg in the treatment of pityriasis rosea: a preliminary report. J Philippine Dermatological Soc. 1996;5:3–7.
   Google Scholar
• Chuh AA, Au TS. Pityriasis rosea – a review of the specific treatments. Proc R Coll Physicians Edinb. 2001;31:203–207.
   Google Scholar
• Tay YK, Goh CL. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore. 1999;28:829–831.
   PubMedGoogle Scholar
• Leonforte JF. Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatologica. 1981;163:480–481.
   PubMedGoogle Scholar
• Sharma PK, Yadav TP, Gautam RK, et al. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2000;42(2 Pt 1):241–244.
   PubMed Web of Science ®Google Scholar
• Rasi A, Tajziehchi L, Savabi-Nasab S. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol. 2008;7:35–38.
   PubMed Web of Science ®Google Scholar
• Villarama C, Lansang P. The efficacy of erythromycin stearate in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. Forthcoming 2003.
   Google Scholar
• Amer A, Fischer H. Azithromycin does not cure pityriasis rosea. Pediatrics. 2006;117:1702–1705.
   PubMed Web of Science ®Google Scholar
• Pandhi D, Singal A, Verma P, et al. The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2014;80:36–40.
   PubMed Web of Science ®Google Scholar
• Chuh AAT. Diagnostic criteria for pityriasis rosea: a prospective case control study for assessment of validity. J Eur Acad Dermatol Venereol. 2003;17:101–103.
   PubMed Web of Science ®Google Scholar
• Zawar V, Chuh A. Applicability of proposed diagnostic criteria of pityriasis rosea – results of a prospective case-control study in India. Indian J Dermatol. 2013;58:439–442.
   PubMedGoogle Scholar
• Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol. 1995;33:996–999.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Iftikhar N, Bashir U, et al. Efficacy of clarithromycin in pityriasis rosea. J Coll Physicians Surg Pak. 2014;24:802–805.
   PubMed Web of Science ®Google Scholar
• Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82–85.
   PubMed Web of Science ®Google Scholar
• Rassai S, Feily A, Sina N, et al. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):24–26.
   PubMed Web of Science ®Google Scholar
• Abercrombie GF. Pityriasis rosea. Proc R Soc Med. 1962;55:556–557.
   PubMedGoogle Scholar
• Chuang TY, Ilstrup DM, Perry HO, et al. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol. 1982;7:80–89.
   PubMed Web of Science ®Google Scholar
• Cheong WK, Wong KS. An epidemiological study of pityriasis rosea in middle road hospital. Singapore Med J. 1989;30:60–62.
   PubMedGoogle Scholar
• Traore A, Korsaga-Some N, Niamba P, et al. Pityriasis rosea in secondary schools in Ouagadougou, Burkina Faso. Ann Dermatol Venereol. 2001;128:605–609.
   PubMed Web of Science ®Google Scholar
• Ehsani A, Esmaily N, Noormohammadpour P, et al. The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea. Indian J Dermatol. 2010 Jul–Sep;55(3):246–248.
   PubMedGoogle Scholar
• Amatya A, Rajouria EA, Karn DK. Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of pityriasis rosea. Kathmandu Univ Med J (KUMJ). 2012;10:57–61.
   PubMedGoogle Scholar
• Ganguly S. A randomized, double-blind, placebo-controlled study of efficacy of oral acyclovir in the treatment of pityriasis rosea. J Clin Diagn Res. 2014;8:YC01–4.
   PubMedGoogle Scholar
• Chuh AAT. Narrow band UVB phototherapy and oral acyclovir for pityriasis rosea. Photodermatol Photoimmunol Photomed. 2004;20:64–65.
   PubMed Web of Science ®Google Scholar
• Arndt KA, Paul BS, Stern RS, et al. Treatment of pityriasis rosea with UV radiation. Arch Dermatol. 1983;119:381–382.
   PubMedGoogle Scholar
• Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol. 1995;33:996–999.
   PubMed Web of Science ®Google Scholar
• Lim SH, Kim SM, Oh BH, et al. Low-dose ultraviolet A1 phototherapy for treating pityriasis rosea. Ann Dermatol. 2009;21:230–236.
   PubMed Web of Science ®Google Scholar
• Björnberg A, Hellgren L. Pityriasis rosea. A statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol. 1962;42(Suppl 50):1–50.
   Google Scholar
• Mucha V. Uber einen der Parakeratosis variegate (Unna) bzw. Pityriasis lichenoides chronica (Neisser-Juliusberg) nahestehenden eigentumlichen Fall. Arch Dermatol Syph (Wien). 1916;123:586–592.
   Google Scholar
• Habermann R. Uber die akut vereaufende, nekrotisierende Unterart der Pityriasis lichenoides (Pityriasis lichenoide et varioliformis acuta). Dermatol Z. 1925;45:42–48.
   Google Scholar
• Juliusberg F. Uber die Pityriasis lichenoides chronica (psoriasiform exanthema). Arch Dermatol Syphilol. 1899;50:359–374.
   Google Scholar
• Degos R, Duperrat B, Daniel F. Le parapsoriasis ulceronecrotique hyperthemique. Ann Derm Syph. 1966;93:481–496.
   PubMedGoogle Scholar
• Neisser A. Zur Frage der lichenoiden Eruptionen. Verh Dtsch Dermatol Ges. 894;4:495–499.
   Google Scholar
• Jadassohn J. Ube rein eingenartiges psoriasiformes und lichenoides Exanthem. Verh Dtsch Dermatol Ges. 1894;4:524–529.
   Google Scholar
• Ersoy-Evans S, Greco MF, Mancini AJ, et al. Pityriasis lichenoides in childhood: a retrospective review of 124 patients. J Am Acad Dermatol. 2007;56(2):205–210.
   PubMed Web of Science ®Google Scholar
• Markus JR, Carvalho VO, Lima MN, et al. The relevance of recognizing clinical and morphologic features of pityriasis lichenoides: clinicopathological study of 29 cases. Dermatol Pract Concept. 2013;31(3):7–10.
   Google Scholar
• Andreev VC, Angelov N, Zlatkov NB. Skin manifestations in toxoplasmosis. Arch Dermatol. 1969;100:196–199.
   PubMedGoogle Scholar
• Zlatkov NB, Andreev VC. Toxoplasmosis and pityriasis lichenoides. Br J Dermatol. 1972;87:114–116.
   PubMed Web of Science ®Google Scholar
• Rongioletti F, Rivera G, Rebora A. Pityriasis lichenoides et varioliformis acuta and acquired toxoplasmosis. Dermatologica. 1987;175:41–44.
   PubMedGoogle Scholar
• Nassef NE, Hammam MA. The relationship between toxoplasmosis and pityriasis lichenoides. J Egypt Soc Parasitol. 1997;27:93–99.
   PubMedGoogle Scholar
• Boralevi F, Cotto E, Baysse L, et al. Is varicella-zoster virus involved in the etiopathogeny of pityriasis lichenoides? J Invest Dermatol. 2003;121:647–648.
   PubMed Web of Science ®Google Scholar
• Tsai KS, Hsieh HJ, Chow KC, et al. Detection of cytomegalovirus infection in a patient with febrile ulceronecrotic Mucha-Habermann’s disease. Int J Dermatol. 2001;40:694–698.
   PubMed Web of Science ®Google Scholar
• Boss JM, Boxley JD, Summerly R, et al. The detection of Epstein Barr virus antibody in “exanthematic” dermatoses with special reference to pityriasis lichenoides: a preliminary survey. Clin Exp Dermatol. 1978;3:51–56.
   PubMed Web of Science ®Google Scholar
• Edwards BL, Bonagura VR, Valacer DJ, et al. Mucha-Habermann’s disease and arthritis: possible association with reactivated Epstein-Barr virus infection. J Rheumatol. 1989;16:387–389.
   PubMed Web of Science ®Google Scholar
• Almagro M, Del Pozo J, Martinez W, et al. Pityriasis lichenoides-like exanthema and primary infection by Epstein-Barr virus. Int J Dermatol. 2000;39:156–159.
   PubMed Web of Science ®Google Scholar
• Klein PA, Jones EC, Nelson JL, et al. Infectious causes of pityriasis lichenoides: a case of fulminant infectious mononucleosis. J Am Acad Dermatol. 2003;49:S151–3.
   PubMed Web of Science ®Google Scholar
• Sabarthe MP, Salomon D, Saurat JH. Ulcerations de la langue, parapsoriasis en gouttes et primo-infection A parvovirus B19. Ann Dermatol Venereol. 1996;123:735–738.
   PubMed Web of Science ®Google Scholar
• Tomasini D, Tomasini CF, Cerri A, et al. Pityriasis lichenoides: a cytotoxic T-cell mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol. 2004;31:531–538.
   PubMed Web of Science ®Google Scholar
• Kempf W, Kazakov DV, Palmedo G, et al. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am J Surg Pathol. 2012;36:1021–1029.
   PubMed Web of Science ®Google Scholar
• Ostlere LS, Langtry JAA, Branfoot AC, et al. HIV seropositivity in association with pityriasis lichenoides et varioliformis acuta. Clin Exp Dermatol. 1992;17:36–37.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Nelson A, Skelton H, et al. Pityriasis lichenoides et varioliformis acuta in HIV1 patients: a marker of early stage disease. Int J Dermatol. 1997;36:104–109.
   PubMed Web of Science ®Google Scholar
• Griffiths JK. Successful long-term use of cyclosporin A in HIV induced pityriasis lichenoides chronica. J Acquir Immun Defic Syndrome Hum Retrovirol. 1998;18:396.
   PubMedGoogle Scholar
• Jc E III, Collins M, Bryant-Bruce C. Pityriasis lichenoides et varioliformis acuta and group A beta hemolytic streptococcal infection. Int J Dermatol. 1995;34:642–646.
   PubMed Web of Science ®Google Scholar
• Piamphongsant T. Tetracycline for the treatment of pityriasis lichenoides. Br J Dermatol. 1974;91:319–322.
   PubMed Web of Science ®Google Scholar
• Torinuki W. Mucha-Habermann disease in a child: possible association with measles vaccination. J Dermatol. 1992;19:253–255.
   PubMedGoogle Scholar
• Gil-Bistes D, Kluger N, Bessis D, et al. Pityriasis lichenoides chronic after measles-mumps-rubella vaccination. J Dermatol. 2012;39:492–493.
   PubMed Web of Science ®Google Scholar
• Gunatheesan S, Ferguson J, Moosa Y. Pityriasis lichenoides et varioliformis acuta: a rare association with the measles, mumps and rubella vaccine. Australas J Dermatol. 2012;53:e76–e78.
   PubMed Web of Science ®Google Scholar
• Wahie S, Hiscutt E, Natarajan S, et al. Pityriasis lichenoides: the differences between children and adults. Br J Dermatol. 2007;157:941–945.
   PubMed Web of Science ®Google Scholar
• López-Ferrer A, Puig L, Moreno G, et al. Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate. Eur J Dermatol. 2010;20(4):511–512.
   PubMed Web of Science ®Google Scholar
• Said BB, Kanitakis J, Graber I, et al. Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn’s disease: report of 2 cases successfully treated with methotrexate. Inflamm Bowel Dis. 2010;16(6):912–913.
   PubMed Web of Science ®Google Scholar
• Meziane L, Caudron A, Dhaille F, et al. Febrile ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Dermatology. 2012;225(4):344–348.
   PubMed Web of Science ®Google Scholar
• Sabatiello M, Willemaers V, Lesuisse M, et al. Pemetrexed-induced pityriasis lichenoides-like dermatitis. J Eur Acad Dermatol Venereol. 2012;26(1):127–129.
   PubMed Web of Science ®Google Scholar
• Machan M, Loren R, Fraga G, et al. Pityriasis lichenoides et varioliformis acuta associated with subcutaneous immunoglobulin administration. J Am Acad Dermatol. 2012;67(4):e151–2.
   PubMed Web of Science ®Google Scholar
• Massay RJ, Maynard AA. Pityriasis lichenoides chronica associated with use of HMG-CoA reductase inhibitors. West Indian Med J. 2012 Oct;61(7):743–745.
   PubMed Web of Science ®Google Scholar
• Newell EL, Jain S, Stephens C, et al. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis. J Eur Acad Dermatol Venereol. 2009;23(2):230–231.
   PubMed Web of Science ®Google Scholar
• Echeverri AF, Vidal A, Cañas CA, et al. Etanercept-induced pityriasis lichenoides chronica in a patient with rheumatoid arthritis. Case Rep Dermatol Med. 2015;2015:168063. doi:10.1155/2015/168063.
   PubMedGoogle Scholar
• Fortson JS, Schroeter AL, Esterly NB. Cutaneous T-cell lymphoma (parapsoriasisen plaque). An association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol. 1990;126(11):1449–1453.
   PubMedGoogle Scholar
• Thomson KF, Whittaker SJ, Russell-Jones R, et al. Childhood cutaneous T-cell lymphoma in association with pityriasis lichenoides chronica. Br J Dermatol. 1999;141(6):1146–1148.
   PubMed Web of Science ®Google Scholar
• Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55:557–572.
   PubMed Web of Science ®Google Scholar
• Geller L, Antonov NK, Lauren CT, et al. Pityriasis lichenoides in childhood: review of clinical presentation and treatment options. Pediatr Dermatol. 2015;32:579–592.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Jia J, Tian Q, et al. Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: two case reports and a literature review. Exp Ther Med. 2014 Dec;8(6):1927–1933.
   PubMed Web of Science ®Google Scholar
• Gameiro A, Gouveia M, Tellechea Ó, et al. Childhood hypopigmented mycosis fungoides: a commonly delayed diagnosis. BMJ Case Rep. 2014;23:2014.
   Google Scholar
• Sotiriou E, Patsatsi A, Tsorova C, et al. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Acta Derm Venereol. 2008;88:350–355.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Kasamatsu M, Yokota M, et al. Mucha-Habermann disease and its febrile ulceronecrotic variant. Cutis. 1996;58:123–130.
   PubMed Web of Science ®Google Scholar
• Kaufman WS, McNamara EK, Curtis AR, et al. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome. Pediatr Dermatol. 2012;29:135–140.
   PubMed Web of Science ®Google Scholar
• Romani J, Puig L, Fernandez-Figueras MT, et al. Pityriasis lichenoides in children: clinicopathologic review of 22 patients. Pediatr Dermatol. 1998;15:1–6.
   PubMed Web of Science ®Google Scholar
• Gelmetti C, Rigoni C, Alessi E, et al. Pityriasis lichenoides in children: a long-term follow-up of eighty-nine cases. J Am Acad Dermatol. 1990;23:473–478.
   PubMed Web of Science ®Google Scholar
• Bulur I, Kaya Erdoğan H, Nurhan Saracoglu Z, et al. Methotrexate treatment in children with febrile ulceronecrotic Mucha-Habermann disease: case report and literature review. Case Rep Dermatol Med. 2015;2015:357973.
   PubMedGoogle Scholar
• Hapa A, Ersoy-Evans S, Karaduman A. Childhood pityriasis lichenoides and oral erythromycin. Pediatr Dermatol. 2012;29(6):719–724.
   PubMed Web of Science ®Google Scholar
• Simon D, Boudny C, Nievergelt H, et al. Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol. 2004;150:1033–1035.
   PubMed Web of Science ®Google Scholar
• Mallipeddi R, Evans AV. Refractory pityriasis lichenoides chronica successfully treated with topical tacrolimus. Clin Exp Dermatol. 2003;28:456–458.
   PubMed Web of Science ®Google Scholar
• Gianotti F. Rilievi di una particolare casistica tossinfettiva caratterizzata de eruzione eritemato-infiltrativa desquamativa a focolai lenticolari, a sede elettiva acroesposta. Giornale italiano di dermatologia e sifilologia [Report on a special case of toxic infection characterized by a desquamative erythemato-infiltrative eruption with lenticular foci and a selective localization at the extremities]. G Ital Dermatol. 1955;96:678–697.
   Google Scholar
• Crosti A, Gianotti F. Dermatosi infantile eruttiva acroesposta di probabile origine virosica. Minerva Dermatol. 1956;31(Suppl):483.
   Google Scholar
• Crosti A, Gianotti F. Eruptive dermatosis of probable viral origin situated on the acra. Dermatologica. 1957;115:671–677.
   PubMedGoogle Scholar
• Crosti A, Gianotti F. Ulteriore contributo alla conoscenza dell’ acrodermatitie papulosa infantile. G Ital Dermatol. 1964;105:477–504.
   PubMedGoogle Scholar
• Ishimaru Y, Ishimaru H, Toda G, et al. An epidemic of infantile papular acrodermatitis (Gianotti’s disease) in Japan associated with hepatitis-B surface antigen subtype ayw. Lancet. 1976;1:707–709.
   PubMed Web of Science ®Google Scholar
• Kanzaki S, Kanda S, Terada K, et al. Detection of hepatitis B surface antigen subtype adr in an epidemic of papular acrodermatitis of childhood (Gianotti’s disease). Acta Med Okayama. 1981;35:407–410.
   PubMed Web of Science ®Google Scholar
• Ono E. Natural history of infantile papular acrodermatitis (Gianotti’s disease) with HBsAg subtype adw. Kurume Med J. 1988;35:147–157.
   PubMedGoogle Scholar
• Baldari U, Monti A, Righini MG. An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus. Dermatology. 1994;188:203–204.
   PubMed Web of Science ®Google Scholar
• Dematteï C, Zawar V, Lee A, et al. Spatial-temporal case clustering in children with Gianotti-Crosti syndrome. Systematic analysis led to the identification of a mini-epidemic. Eur J Pediatr Dermatol. 2006;16:159–164.
   PubMed Web of Science ®Google Scholar
• Toda G. Gianotti disease and Gianotti-Crosti syndrome. Ryoikibetsu Shokogun Shirizu. 1995;7:24–26.
   PubMedGoogle Scholar
• Caputo R, Gelmetti C, Ermacora E, et al. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol. 1992;26:207–210.
   PubMed Web of Science ®Google Scholar
• San Joaquin VH, Marks MI. Gianotti disease or Gianotti-Crosti syndrome? J Pediatr. 1982;101:217–218.
   PubMed Web of Science ®Google Scholar
• Taïeb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndromeea study of 26 cases. Br J Dermatol. 1986;115:49–59.
   PubMed Web of Science ®Google Scholar
• Gelmetti CM. Gianotti-Crosti syndrome. In: Irvine AD, Hoeger PH, Yan AC editors. Harper’s textbook of pediatric dermatology. 3rd ed. Oxford: Wiley-Blackwell, a John Wiley & Sons Ltd Publication; 2011. Chapter 50, p. 50.1–50.6 (ISBN: 978-1-4051-7695-8).
   Google Scholar
• Taïeb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol. 1986;115:49–59.
   PubMed Web of Science ®Google Scholar
• Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol. 2004;51:606–624.
   PubMed Web of Science ®Google Scholar
• Chuh AAT. Truncal lesions do not exclude a diagnosis of Gianotti-Crosti syndrome. Australas J Dermatol. 2003;44:215–216.
   PubMedGoogle Scholar
• Chuh AAT. Diagnostic criteria for Gianotti-Crosti syndrome – a prospective case control study for validity assessment. Cutis. 2001;68:207–213.
   PubMed Web of Science ®Google Scholar
• Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome – are they applicable to children in India? Pediatr Dermatol. 2004;21:542–547.
   PubMed Web of Science ®Google Scholar
• Chuh A, Zawar V, Law M, et al. Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. Infect Dis Rep. 2012;4:12–48.
   Google Scholar
• Chuh AAT. Pediatric viral exanthems. Yearbook of dermatology and dermatologic surgery. US: Mosby, Elsevier; 2005. p. 16–43. (ISBN: 0-323-02105-0).
   Google Scholar
• Zawar V, Chuh A. Efficacy of ribavirin in a case of long lasting and disabling Gianotti-Crosti syndrome. J Dermatol Case Rep. 2009;2:63–66.
   Google Scholar
• Kempkes B, Robertson ES. Epstein-Barr virus latency: current and future perspectives. Curr Opin Virol. 2015;14:138–144.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Matsusaka K, Aburatani H, et al. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res. 2012;72:3445–3450.
   PubMed Web of Science ®Google Scholar
• Virtanen JO, Jacobson S. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets. 2012;11:528–544.
   PubMed Web of Science ®Google Scholar
• Chuh A, Dofitas B, Comisel G, et al. Interventions for pityriasis rosea – a protocol. Cochrane Database Syst Rev. 2005;1. Art No: CD005068. doi:10.1002/14651858.
   Google Scholar
• Toda G. Gianotti-Crosti syndrome and Gianotti disease. Ryoikibetsu Shokogun Shirizu. 1999;24(Pt 2):137–140.
   PubMedGoogle Scholar
• Rosman IS, Liang LC, Patil S, et al. Febrile ulceronecrotic Mucha-Habermann disease with central nervous system vasculitis. Pediatr Dermatol. 2013;30:90–93.
   PubMed Web of Science ®Google Scholar